Furthermore, ASF1B has been shown to promote the proliferation and invasion of clear cell renal cell carcinoma and gastric cancer cells through the activation of the AKT and Bax/Bcl-2-p53 pathways (31, 32). Here, BCL2 is linked to clear cell renal carcinoma.